Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
January-2017 Volume 39 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2017 Volume 39 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Nobiletin, a citrus flavonoid, activates vasodilator-stimulated phosphoprotein in human platelets through non-cyclic nucleotide-related mechanisms

Corrigendum in: /10.3892/ijmm.2019.4422
  • Authors:
    • Thanasekaran Jayakumar
    • Kao-Chang Lin
    • Wan-Jung Lu
    • Chia-Ying Lin
    • Geraldine Pitchairaj
    • Jiun-Yi Li
    • Joen-Rong Sheu
  • View Affiliations / Copyright

    Affiliations: Department of Pharmacology, College of Medicine, Taipei Medical University, Taipei, Taiwan, R.O.C., Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan, R.O.C., Department of Animal Science, School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India
    Copyright: © Jayakumar et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 174-182
    |
    Published online on: December 7, 2016
       https://doi.org/10.3892/ijmm.2016.2822
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Nobiletin, a bioactive polymethoxylated flavone, has been described to possess a diversity of biological effects through its antioxidant and anti-inflammatory properties. Vasodilator-stimulated phosphoprotein (VASP) is a common substrate for cyclic AMP and cyclic GMP-regulated protein kinases [i.e., cyclic AMP-dependent protein kinase (PKA; also known as protein kinase A) and cyclic GMP-dependent protein kinase (PKG; also known as protein kinase G)] and it has been shown to be directly phosphorylated by protein kinase C (PKC). In the present study, we demonstrate that VASP is phosphorylated by nobiletin in human platelets via a non-cyclic nucleotide-related mechanism. This was confirmed by the use of inhibitors of adenylate cyclase (SQ22536) and guanylate cyclase [1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ)], since they prevented VASP phosphorylation induced by nobiletin. Furthormore, this event was also not affected by specific inhibitors of PKA (H-89), PKG (KT5823) and PKC (Ro318220), representing cyclic nucleotide-dependent pathways upon nobiletin-induced VASP phosphorylation. Similarly, inhibitors of p38 mitogen-activated protein kinase (MAPK; SB203580), extracellular signal-regulated kinase 2 (ERK2; PD98059), c-Jun N-terminal kinase 1 (JNK1; SP600125), Akt (LY294002) and nuclear factor-κB (NF-κB; Bay11-7082) did not affect nobiletin‑induced VASP phosphorylation. Moreover, electron spin resonance, dichlorofluorescein fluorescence and western blotting techniques revealed that nobiletin did not affect hydroxyl radicals (OH•), intracellular reactive oxygen species (ROS) and on protein carbonylation, respectively. Furthermore, the nobiletin‑induced VASP phosphorylation was surprisingly reversed by the intracellular antioxidant, N-acetylcysteine (NAC), but not by the inhibitor of NADPH oxidase, diphenyleneiodonium chloride (DPI). It was surprising to observe the differential effects of nobiletin and NAC on VASP phosphorylation in human platelets, since they both have been reported to have antioxidant properties. The likely explanation for this discrepancy is that NAC may bind to allosteric sites on the receptor different from those that nobiletin binds to in human platelets. Taken together, our findings suggest that nobiletin induces VASP phosphorylation in human platelets through non-cyclic nucleotide-related mechanisms. Nevertheless, the exact mechanisms responsible for these effects need to be further confirmed in future studies.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Manthey JA and Grohmann K: Phenols in citrus peel byproducts. Concentrations of hydroxycinnamates and polymethoxylated flavones in citrus peel molasses. J Agric Food Chem. 49:3268–3273. 2001. View Article : Google Scholar : PubMed/NCBI

2 

Nakajima A, Aoyama Y, Shin EJ, Nam Y, Kim HC, Nagai T, Yokosuka A, Mimaki Y, Yokoi T, Ohizumi Y and Yamada K: Nobiletin, a citrus flavonoid, improves cognitive impairment and educes soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD). Behav Brain Res. 289:69–77. 2015. View Article : Google Scholar : PubMed/NCBI

3 

Kawahata I, Yoshida M, Sun W, Nakajima A, Lai Y, Osaka N, Matsuzaki K, Yokosuka A, Mimaki Y, Naganuma A, et al: Potent activity of nobiletin-rich Citrus reticulata peel extract to facilitate cAMP/PKA/ERK/CREB signaling associated with learning and memory in cultured hippocampal neurons: identification of the substances responsible for the pharmacological action. J Neural Transm (Vienna). 120:1397–1409. 2013. View Article : Google Scholar

4 

Kawaii S, Tomono Y, Katase E, Ogawa K and Yano M: Quantitation of flavonoid constituents in citrus fruits. J Agric Food Chem. 47:3565–3571. 1999. View Article : Google Scholar : PubMed/NCBI

5 

Xiong Y, Chen D, Yu C, Lv B, Peng J, Wang J and Lin Y: Citrus nobiletin ameliorates experimental colitis by reducing inflammation and restoring impaired intestinal barrier function. Mol Nutr Food Res. 59:829–842. 2015. View Article : Google Scholar : PubMed/NCBI

6 

Wu YQ, Zhou CH, Tao J and Li SN: Antagonistic effects of nobiletin, a polymethoxyflavonoid, on eosinophilic airway inflammation of asthmatic rats and relevant mechanisms. Life Sci. 178:2689–2696. 2006. View Article : Google Scholar

7 

Lu YH, Su MY, Huang HY, Lin-Li and Yuan CG: Protective effects of the citrus flavanones to PC12 cells against cytotoxicity induced by hydrogen peroxide. Neurosci Lett. 484:6–11. 2010. View Article : Google Scholar : PubMed/NCBI

8 

Choi BK, Kim TW, Lee DR, Jung WH, Lim JH, Jung JY, Yang SH and Suh JW: A polymethoxy flavonoids-rich Citrus aurantium extract ameliorates ethanol-induced liver injury through modulation of AMPK and Nrf2-related signals in a binge drinking mouse model. Phytother Res. 29:1577–1584. 2015. View Article : Google Scholar : PubMed/NCBI

9 

Cui Y, Wu J, Jung SC, Park DB, Maeng YH, Hong JY, Kim SJ, Lee SR, Kim SJ, Kim SJ, et al: Anti-neuroinflammatory activity of nobiletin on suppression of microglial activation. Biol Pharm Bull. 33:1814–1821. 2010. View Article : Google Scholar : PubMed/NCBI

10 

Ho SC and Kuo CT: Hesperidin, nobiletin, and tangeretin are collectively responsible for the anti-neuroinflammatory capacity of tangerine peel (Citri reticulatae pericarpium). Food Chem Toxicol. 71:176–182. 2014. View Article : Google Scholar : PubMed/NCBI

11 

Zhang L, Zhao H, Zhang X, Chen L, Zhao X, Bai X and Zhang J: Nobiletin protects against cerebral ischemia via activating the p-Akt, p-CREB, BDNF and Bcl-2 pathway and ameliorating BBB permeability in rat. Brain Res Bull. 96:45–53. 2013. View Article : Google Scholar : PubMed/NCBI

12 

Benz PM, Blume C, Seifert S, Wilhelm S, Waschke J, Schuh K, Gertler F, Münzel T and Renné T: Differential VASP phosphorylation controls remodeling of the actin cytoskeleton. J Cell Sci. 122:3954–3965. 2009. View Article : Google Scholar : PubMed/NCBI

13 

Major TC, Handa H, Brisbois EJ, Reynolds MM, Annich GM, Meyerhoff ME and Bartlett RH: The mediation of platelet quiescence by NO-releasing polymers via cGMP-induced serine 239 phosphorylation of vasodilator-stimulated phosphoprotein. Biomaterials. 34:8086–8096. 2013. View Article : Google Scholar : PubMed/NCBI

14 

Lee DH, Cho HJ, Kim HH, Rhee MH, Ryu JH and Park HJ: Inhibitory effects of total saponin from Korean red ginseng via vasodilator-stimulated phosphoprotein-Ser(157) phosphorylation on thrombin-induced platelet aggregation. J Ginseng Res. 37:176–186. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Aszódi A, Pfeifer A, Ahmad M, Glauner M, Zhou XH, Ny L, Andersson KE, Kehrel B, Offermanns S and Fässler R: The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function. EMBO J. 18:37–48. 1999. View Article : Google Scholar : PubMed/NCBI

16 

Eckly-Michel A, Martin V and Lugnier C: Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation. Br J Pharmacol. 122:158–164. 1997. View Article : Google Scholar : PubMed/NCBI

17 

Chitaley K, Chen L, Galler A, Walter U, Daum G and Clowes AW: Vasodilator-stimulated phosphoprotein is a substrate for protein kinase C. FEBS Lett. 556:211–215. 2004. View Article : Google Scholar : PubMed/NCBI

18 

Horstrup K, Jablonka B, Hönig-Liedl P, Just M, Kochsiek K and Walter U: Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition. Eur J Biochem. 225:21–27. 1994. View Article : Google Scholar : PubMed/NCBI

19 

Hauser W, Knobeloch KP, Eigenthaler M, Gambaryan S, Krenn V, Geiger J, Glazova M, Rohde E, Horak I, Walter U and Zimmer M: Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice. Proc Natl Acad Sci USA. 96:8120–8125. 1999. View Article : Google Scholar : PubMed/NCBI

20 

Lu WJ, Lin KC, Liu CP, Lin CY, Wu HC, Chou DS, Geraldine P, Huang SY, Hsieh CY and Sheu JR: Prevention of arterial thro mbosis by nobiletin: in vitro and in vivo studies. J Nutr Biochem. 28:1–8. 2016. View Article : Google Scholar : PubMed/NCBI

21 

Vaiyapuri S, Roweth H, Ali MS, Unsworth AJ, Stainer AR, Flora GD, Crescente M, Jones CI, Moraes LA and Gibbins JM: Pharmacological actions of nobiletin in the modulation of platelet function. Br J Pharmacol. 172:4133–4145. 2015. View Article : Google Scholar : PubMed/NCBI

22 

Sheu JR, Lee CR, Lin CH, Hsiao G, Ko WC, Chen YC and Yen MH: Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets. Thromb Haemost. 83:777–784. 2000.PubMed/NCBI

23 

Chou DS, Hsiao G, Shen MY, Tsai YJ, Chen TF and Sheu JR: ESR spin trapping of a carbon-centered free radical from agonist-stimulated human platelets. Free Radic Biol Med. 39:237–248. 2005. View Article : Google Scholar : PubMed/NCBI

24 

Smolenski A, Bachmann C, Reinhard K, Hönig-Liedl P, Jarchau T, Hoschuetzky H and Walter U: Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phospho-specific monoclonal antibody. J Biol Chem. 273:20029–20035. 1998. View Article : Google Scholar : PubMed/NCBI

25 

Pula G, Schuh K, Nakayama K, Nakayama KI, Walter U and Poole AW: PKCdelta regulates collagen-induced platelet aggregation through inhibition of VASP-mediated filopodia formation. Blood. 108:4035–4044. 2006. View Article : Google Scholar : PubMed/NCBI

26 

Butt E, Abel K, Krieger M, Palm D, Hoppe V, Hoppe J and Walter U: cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets. J Biol Chem. 269:14509–14517. 1994.PubMed/NCBI

27 

Liu F, Morris S, Epps J and Carroll R: Demonstration of an activation regulated NF-kappaB/I-kappaBalpha complex in human platelets. Thromb Res. 106:199–203. 2002. View Article : Google Scholar : PubMed/NCBI

28 

Seno T, Inoue N, Gao D, Okuda M, Sumi Y, Matsui K, Yamada S, Hirata KI, Kawashima S, Tawa R, et al: Involvement of NADH/NADPH oxidase in human platelet ROS production. Thromb Res. 103:399–409. 2001. View Article : Google Scholar : PubMed/NCBI

29 

Gülçin I, Elmastaş M and Aboul-Enein HY: Determination of antioxidant and radical scavenging activity of Basil (Ocimum basilicum L. Family Lamiaceae) assayed by different methodologies. Phytother Res. 21:354–361. 2007. View Article : Google Scholar : PubMed/NCBI

30 

Kuczmannová A, Gál P, Varinská L, Treml J, Kováč I, Novotný M, Vasilenko T, Dall'Acqua S, agy M and Mučaji P: Agrimonia eupatoria L. and Cynara cardunculus L. Water Infusions: Phenolic profile and comparison of antioxidant activities. Molecules. 20:20538–20550. 2015. View Article : Google Scholar : PubMed/NCBI

31 

Timmers MA, Guerrero-Medina JL, Esposito D, Grace MH, Paredes-López O, García-Saucedo PA and Lila MA: Characterization of phenolic compounds and antioxidant and anti-inflammatory activities from mamuyo (Styrax ramirezii Greenm.) fruit. J Agric Food Chem. 63:10459–10465. 2015. View Article : Google Scholar : PubMed/NCBI

32 

Alexandru N, Constantin A and Popov D: Carbonylation of platelet proteins occurs as consequence of oxidative stress and thrombin activation, and is stimulated by ageing and type 2 diabetes. Clin Chem Lab Med. 46:528–536. 2008. View Article : Google Scholar : PubMed/NCBI

33 

Massberg S, Grüner S, Konrad I, Garcia Arguinzonis MI, Eigenthaler M, Hemler K, Kersting J, Schulz C, Muller I, Besta F, et al: Enhanced in vivo platelet adhesion in vasodilator-stimulated phosphoprotein (VASP)-deficient mice. Blood. 103:136–142. 2004. View Article : Google Scholar

34 

Halbrügge M, Friedrich C, Eigenthaler M, Schanzenbächer P and Walter U: Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP- and cAMP-elevating vasodilators. J Biol Chem. 265:3088–3093. 1990.PubMed/NCBI

35 

Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP and Waldman SA: Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev. 52:375–414. 2000.PubMed/NCBI

36 

Butt E, van Bemmelen M, Fischer L, Walter U and Jastorff B: Inhibition of cGMP-dependent protein kinase by (Rp)-guanosine 3′,5′-monophosphorothioates. FEBS Lett. 263:47–50. 1990. View Article : Google Scholar : PubMed/NCBI

37 

Lu WJ, Lee JJ, Chou DS, Jayakumar T, Fong TH, Hsiao G and Sheu JR: A novel role of andrographolide, an NF-kappa B inhibitor, on inhibition of platelet activation: the pivotal mechanisms of endothelial nitric oxide synthase/cyclic GMP. J Mol Med (Berl). 89:1261–1273. 2011. View Article : Google Scholar

38 

Dorsam RT, Kim S, Jin J and Kunapuli SP: Coordinated signaling through both G12/13 and G(i) pathways is sufficient to activate GPIIb/IIIa in human platelets. J Biol Chem. 277:47588–47595. 2002. View Article : Google Scholar : PubMed/NCBI

39 

Adam F, Kauskot A, Rosa JP and Bryckaert M: Mitogen-activated protein kinases in hemostasis and thrombosis. J Thromb Haemost. 6:2007–2016. 2008. View Article : Google Scholar : PubMed/NCBI

40 

Kauskot A, Adam F, Mazharian A, Ajzenberg N, Berrou E, Bonnefoy A, Rosa JP, Hoylaerts MF and Bryckaert M: Involvement of the mitogen-activated protein kinase c-Jun NH2-terminal kinase 1 in thrombus formation. J Biol Chem. 282:31990–31999. 2007. View Article : Google Scholar : PubMed/NCBI

41 

Kuliopulos A, Mohanlal R and Covic L: Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation. Thromb Haemost. 92:1387–1393. 2004.PubMed/NCBI

42 

Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T and Gerritsen ME: Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem. 272:21096–21103. 1997. View Article : Google Scholar : PubMed/NCBI

43 

Lee HS, Kim SD, Lee WM, Endale M, Kamruzzaman SM, Oh WJ, Cho JY, Kim SK, Cho HJ, Park HJ, et al: A noble function of BAY 11-7082: inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations. Eur J Pharmacol. 627:85–91. 2010. View Article : Google Scholar

44 

Sheu JR, Hung WC, Wu CH, Ma MC, Kan YC, Lin CH, Lin MS, Luk HN and Yen MH: Reduction in lipopolysaccharide-induced thrombocytopenia by triflavin in a rat model of septicemia. Circulation. 99:3056–3062. 1999. View Article : Google Scholar : PubMed/NCBI

45 

Berg C, Trofast C and Bengtsson T: Platelets induce reactive oxygen species-dependent growth of human skin fibroblasts. Eur J Cell Biol. 82:565–571. 2003. View Article : Google Scholar

46 

Anfossi G, Russo I, Massucco P, Mattiello L, Cavalot F and Trovati M: N-acetyl-L-cysteine exerts direct anti-aggregating effect on human platelets. Eur J Clin Invest. 31:452–461. 2001. View Article : Google Scholar : PubMed/NCBI

47 

Radomski MW, Palmer RMJ and Moncada S: An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA. 87:5193–5197. 1990. View Article : Google Scholar : PubMed/NCBI

48 

Moro MA, Russel RJ, Cellek S, Lizasoain I, Su Y, Darley-Usmar VM, Radomski MW and Moncada S: cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci USA. 93:1480–1485. 1996. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Jayakumar T, Lin K, Lu W, Lin C, Pitchairaj G, Li J and Sheu J: Nobiletin, a citrus flavonoid, activates vasodilator-stimulated phosphoprotein in human platelets through non-cyclic nucleotide-related mechanisms Corrigendum in /10.3892/ijmm.2019.4422. Int J Mol Med 39: 174-182, 2017.
APA
Jayakumar, T., Lin, K., Lu, W., Lin, C., Pitchairaj, G., Li, J., & Sheu, J. (2017). Nobiletin, a citrus flavonoid, activates vasodilator-stimulated phosphoprotein in human platelets through non-cyclic nucleotide-related mechanisms Corrigendum in /10.3892/ijmm.2019.4422. International Journal of Molecular Medicine, 39, 174-182. https://doi.org/10.3892/ijmm.2016.2822
MLA
Jayakumar, T., Lin, K., Lu, W., Lin, C., Pitchairaj, G., Li, J., Sheu, J."Nobiletin, a citrus flavonoid, activates vasodilator-stimulated phosphoprotein in human platelets through non-cyclic nucleotide-related mechanisms Corrigendum in /10.3892/ijmm.2019.4422". International Journal of Molecular Medicine 39.1 (2017): 174-182.
Chicago
Jayakumar, T., Lin, K., Lu, W., Lin, C., Pitchairaj, G., Li, J., Sheu, J."Nobiletin, a citrus flavonoid, activates vasodilator-stimulated phosphoprotein in human platelets through non-cyclic nucleotide-related mechanisms Corrigendum in /10.3892/ijmm.2019.4422". International Journal of Molecular Medicine 39, no. 1 (2017): 174-182. https://doi.org/10.3892/ijmm.2016.2822
Copy and paste a formatted citation
x
Spandidos Publications style
Jayakumar T, Lin K, Lu W, Lin C, Pitchairaj G, Li J and Sheu J: Nobiletin, a citrus flavonoid, activates vasodilator-stimulated phosphoprotein in human platelets through non-cyclic nucleotide-related mechanisms Corrigendum in /10.3892/ijmm.2019.4422. Int J Mol Med 39: 174-182, 2017.
APA
Jayakumar, T., Lin, K., Lu, W., Lin, C., Pitchairaj, G., Li, J., & Sheu, J. (2017). Nobiletin, a citrus flavonoid, activates vasodilator-stimulated phosphoprotein in human platelets through non-cyclic nucleotide-related mechanisms Corrigendum in /10.3892/ijmm.2019.4422. International Journal of Molecular Medicine, 39, 174-182. https://doi.org/10.3892/ijmm.2016.2822
MLA
Jayakumar, T., Lin, K., Lu, W., Lin, C., Pitchairaj, G., Li, J., Sheu, J."Nobiletin, a citrus flavonoid, activates vasodilator-stimulated phosphoprotein in human platelets through non-cyclic nucleotide-related mechanisms Corrigendum in /10.3892/ijmm.2019.4422". International Journal of Molecular Medicine 39.1 (2017): 174-182.
Chicago
Jayakumar, T., Lin, K., Lu, W., Lin, C., Pitchairaj, G., Li, J., Sheu, J."Nobiletin, a citrus flavonoid, activates vasodilator-stimulated phosphoprotein in human platelets through non-cyclic nucleotide-related mechanisms Corrigendum in /10.3892/ijmm.2019.4422". International Journal of Molecular Medicine 39, no. 1 (2017): 174-182. https://doi.org/10.3892/ijmm.2016.2822
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team